Physician profile
Jeffrey R Brinker
NPI 1538142484
$585.83
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $114.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $110.60 | 2019 | |
| Amgen INC. | $72.68 | 2019 | |
| Amarin Pharma, INC. | $49.41 | 2019 | |
| Pfizer INC. | $47.19 | 2019 | |
| Lilly USA, LLC | $34.63 | 2019 | |
| Sanofi-Aventis U.S. LLC | $26.70 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.49 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.45 | 2019 | |
| Astellas Pharma US INC | $15.68 | 2019 | |
| Sanofi Pasteur INC. | $15.19 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.31 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.15 | 2019 | |
| Glaxosmithkline, LLC. | $12.78 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.29 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $10.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Brinker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.